The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of baseline medications on response to immunotherapy in hepatocellular carcinoma.
 
Tomi Jun
No Relationships to Disclose
 
Sirish Dharmapuri
No Relationships to Disclose
 
Thomas Urban Marron
Consulting or Advisory Role - Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Atara Biotherapeutics; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Genentech; Genentech; Genentech; Genentech; Regeneron; Regeneron; Regeneron; Regeneron
Research Funding - Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Atara Biotherapeutics (Inst); Genentech; Genentech; Genentech; Genentech
 
Max W. Sung
Consulting or Advisory Role - Bayer; Bayer; Bayer; Bayer; Eisai; Eisai; Eisai; Eisai; Exelixis; Exelixis; Exelixis; Exelixis
 
Celina Ang
No Relationships to Disclose